MedTrace Logo

Recombinant Human Platelet-derived Growth Factor in Combination With Collagen Matrix

NCT04462237 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-09-28

No results posted yet for this study

Summary

The present randomized clinical trial is aimed at evaluating the efficacy of recombinant human platelet-derived growth factor in combination with collagen matrix for the treatment of multiple adjacent gingival recessions

Conditions

  • Gingival Recession
  • Platelet Derived Growth Factor

Interventions

PROCEDURE

Root coverage procedures

Treatment of multiple adjacent gingival recession using a coronally advanced flap

Sponsors & Collaborators

Principal Investigators

  • Lorenzo Tavelli, DDS, MS · University of Michigan

  • William Giannobile, DDS, MS, DMSc · University of Michigan

  • Hom-Lay Wang, DDS, MS, PhD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-09
Primary Completion
2021-08-18
Completion
2021-08-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04462237 on ClinicalTrials.gov